Table of Contents
International Scholarly Research Notices
Volume 2017, Article ID 2624947, 7 pages
https://doi.org/10.1155/2017/2624947
Research Article

Formulation and Development of a Validated UV-Spectrophotometric Analytical Method of Rutin Tablet

1Department of Pharmacy, Faculty of Medicine & Health Sciences, An-Najah National University, P.O. Box 7, Nablus, State of Palestine
2Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

Correspondence should be addressed to Murad N. Abualhasan; ude.hajan@nasahlauba_m

Received 4 February 2017; Revised 20 March 2017; Accepted 29 March 2017; Published 16 May 2017

Academic Editor: Josep Esteve-Romero

Copyright © 2017 Murad N. Abualhasan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sharma, A. Ali, J. Ali, J. K. Sahni, and S. Baboota, “Rutin: therapeutic potential and recent advances in drug delivery,” Expert Opinion on Investigational Drugs, vol. 22, no. 8, pp. 1063–1079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Karthick and P. S. M. Prince, “Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats,” Journal of Pharmacy and Pharmacology, vol. 58, no. 5, pp. 701–707, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Nassiri-Asl, T. Naserpour Farivar, E. Abbasi et al., “Effects of rutin on oxidative stress in mice with kainic acid-induced seizure,” Journal of Integrative Medicine, vol. 11, no. 5, pp. 337–342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Kuntić, N. Pejić, B. Ivković et al., “Isocratic RP-HPLC method for rutin determination in solid oral dosage forms,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 2, pp. 718–721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Xu, Y. Li, H.-W. Tang, C.-M. Liu, and Q.-S. Wu, “Determination of rutin with UV-Vis spectrophotometric and laser-induced fluorimetric detections using a non-scanning spectrometer,” Analytical Letters, vol. 43, no. 6, pp. 893–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Parkash, S. Maan, Deepika, S. Yadav, H. Hemlata, and V. Jogpal, “Fast disintegrating tablets: opportunity in drug delivery system,” Journal of Advanced Pharmaceutical Technology and Research, vol. 2, no. 4, pp. 223–235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Norman, R. D. Madurawe, C. M. Moore, M. A. Khan, and A. Khairuzzaman, “A new chapter in pharmaceutical manufacturing: 3D-printed drug products,” Advanced Drug Delivery Reviews, vol. 108, pp. 39–50, 2017. View at Publisher · View at Google Scholar
  8. G. Jean-Marie and R. Denise, Pharmaceutical Manufacturing. Pharmaceutical Dosage Forms—Tablets, CRC Press, 2008.
  9. S. K. Niazi, “Approved excipients in compressed solid dosage forms,” in Handbook of Pharmaceutical Manufacturing Formulations, pp. 99–169, CRC Press, 2009. View at Google Scholar
  10. B. Paul, “Pharmaceutical excipient development—a preclinical challenge,” in Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems, chapter 3, pp. 15–36, CRC Press, 2006. View at Publisher · View at Google Scholar
  11. P. Araujo, “Key aspects of analytical method validation and linearity evaluation,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 23, pp. 2224–2234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. S. Clarke, “The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratories,” Journal of Pharmaceutical and Biomedical Analysis, vol. 12, no. 5, pp. 643–652, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. C. H. Chau, O. Rixe, H. McLeod, and W. D. Figg, “Validation of analytic methods for biomarkers used in drug development,” Clinical Cancer Research, vol. 14, no. 19, pp. 5967–5976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Tiwari and R. Tiwari, “Bioanalytical method validation: an updated review,” Pharmaceutical Methods, vol. 1, no. 1, pp. 25–38, 2010. View at Publisher · View at Google Scholar
  15. M. Swartz and I. S. Krull, “Method validation basics,” in Handbook of Analytical Validation, CRC Press, 2012. View at Google Scholar
  16. M. Bakshi and S. Singh, “Development of validated stability-indicating assay methods—critical review,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1011–1040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. M. Attia, M. W. I. Nassar, M. B. El-Zeiny, and A. Serag, “Stability-indicating methods for the analysis of ciprofloxacin in the presence of its acid induced degradation product: a comparative study,” Spectrochimica Acta. Part A: Molecular and Biomolecular Spectroscopy, vol. 159, pp. 219–222, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Rustichelli, S. Castiglia, M. Gunetti et al., “Validation of analytical methods in compliance with good manufacturing practice: a practical approach,” Journal of Translational Medicine, vol. 11, no. 1, article 197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. <905> Uniformity of dosage unit, United States Pharmacopoeia, 2011.
  20. J. Mansour, M. Abualhasan, and N. Jaradat, Analytical and dissolution method development and validation for a home formulated rutin tablet [M.S. thesis], An-Najah National University, 2015.
  21. C. C. Chan, Y. C. Lee, H. Lam, and X. M. Zhang, Analytical Method Validation and Instrument Performance Verification, John Wiley & Sons, 2004.
  22. International Conference on Harmonisation, “Guidance on Q4B evaluation and recommendation of pharmacopoeial texts,” Federal Register, vol. 73, no. 35, pp. 9575-9576, 2008. View at Google Scholar
  23. <711> Dissolution. United states pharmacopeia, 2011.
  24. J. Emami, “In vitro—in vivo correlation: from theory to applications,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 9, no. 2, pp. 169–189, 2006. View at Google Scholar · View at Scopus
  25. D. Fortunato, “Dissolution method development for immediate release solid oral dosage forms,” Dissolution Technologies, vol. 12, no. 3, pp. 12–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. G. Gupta, S. Ram, and S. Ganga, “Development of discriminating dissolution method for an insoluble drug: nisoldipine,” International Journal of PharmTech Research, vol. 2, no. 1, pp. 931–939, 2010. View at Google Scholar
  27. <701> Disintegration, United States Pharmacopoeia, 2011.